Evidence map›Paper›PMID 40877982›Full record

ReviewStem cell research & therapy2025

Stem cell-based human embryo models: current knowledge and open questions.

Margit Rosner, Stefanie Horer, Izabella Kiss, Markus Hengstschläger

Abstract readReview
In one paragraph

Review in Stem cell research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Margit RosnerInstitute of Medical Genetics, Center for Pathobiochemistry and Genetics, Medical University of Vienna, Währinger Straße 10, 1090, Vienna, Austria.
Stefanie HorerInstitute of Medical Genetics, Center for Pathobiochemistry and Genetics, Medical University of Vienna, Währinger Straße 10, 1090, Vienna, Austria.
Izabella KissInstitute of Medical Genetics, Center for Pathobiochemistry and Genetics, Medical University of Vienna, Währinger Straße 10, 1090, Vienna, Austria.
Markus HengstschlägerInstitute of Medical Genetics, Center for Pathobiochemistry and Genetics, Medical University of Vienna, Währinger Straße 10, 1090, Vienna, Austria. markus.hengstschlaeger@meduniwien.ac.at.ORCID http://orcid.org/0000-0002-3342-7583

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, the research field revolving around the stem cell-based modeling of the human embryo gained particular momentum when the first integrated models were designed with the aim to recapitulate the development of the entire early human conceptus. The underlying driving force to reconstruct embryo-like structures is the prospect of a more comprehensive understanding of the fundamental processes controlling early human embryogenesis including their deregulation causing reproductive failures, and the endeavor to use these embryo models for drug testing and disease modeling. Although efforts will continue to create improved models with steadily increasing fidelity to human embryogenesis, the next phase focusing on the application of human embryo models as a platform to address particular scientific questions is currently being entered. In this review, we discuss the benefits, promises and limitations associated with the use of non-integrated and integrated stem cell-based human embryo models in translational research and biomedical applications.

Indexed as

Embryo, MammalianEmbryonic DevelopmentModels, BiologicalHumans

Identifiers

PMID40877982
PMCPMC12395930

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.